Atlas Trials

Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food

Clinical trial NCT01483170 · TERMINATED

Trial details

NCT number
NCT01483170
Sponsor
Drugs for Neglected Diseases
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Trypanosomiasis, African
Start date
2011-09-01
Primary completion
2011-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.